UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Proximal humeral fractures in Sweden—a registry-based study

Osteoporosis international, 2017-03, Vol.28 (3), p.901-907

2017

Volltextzugriff (PDF)

Postponing elective surgery due to COVID-19 did not decrease the oncological surgery rate in Finland

British journal of surgery, 2021-05, Vol.108 (5), p.e191-e193

2021

Volltextzugriff (PDF)

Cause of death and prognosis of patients (pts) with primary refractory disease, and prognosis of pts reaching PFS24: Descriptive analysis of POLARIX

Hematological oncology, 2023-06, Vol.41 (S2), p.432-433

2023

Volltextzugriff (PDF)

MSR38 Comparison of Mixture-Cure Model Versus Standard Parametric Survival Model in 1L Diffuse Large B-Cell Lymphoma

Value in health, 2022-07, Vol.25 (7), p.S525

2022

Volltextzugriff (PDF)

CLINICAL OUTCOMES OF PATIENTS WITH INTERMEDIATE‐TO‐HIGH‐RISK FOLLICULAR LYMPHOMA (FL) IN THE GALLIUM PHASE III STUDY

Hematological oncology, 2019-06, Vol.37 (S2), p.386-387

2019

Volltextzugriff (PDF)

3D follow‐up study of facial asymmetry after developmental dysplasia of the hip

Orthodontics & craniofacial research, 2018-08, Vol.21 (3), p.146-152

2018

Volltextzugriff (PDF)

ESTIMATION OF LONG‐TERM SURVIVAL WITH POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB FOR PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)

Hematological oncology, 2019-06, Vol.37 (S2), p.257-258

2019

Volltextzugriff (PDF)

PNS30 COST-EFFECTIVENESS MODELING FRAMEWORK FOR MATCHING-ADJUSTED-INDIRECT-COMPARISONS IN THE PRESENCE OF CURE ESTIMATES

Value in health, 2020-05, Vol.23, p.S289-S289

2020

Volltextzugriff (PDF)

Incidence for volar locking plate removal following distal radius fracture surgery

Archives of orthopaedic and trauma surgery, 2021-08, Vol.141 (8), p.1297-1302

2021

Volltextzugriff (PDF)

PCN92 Cost Effectiveness of Obinutuzumab PLUS Chemotherapy Followed By Obinutuzumab Maintenance for Patient with Previously Untreated Advanced-STAGE Follicular Lymphoma in French Setting

Value in health, 2020-12, Vol.23, p.S438-S438

2020

Volltextzugriff (PDF)

POSB109 Cost-Effectiveness and Cost-Utility Analyses of Polatuzumab Vedotin with Bendamustine and Rituximab vs. Bendamustine and Rituximab for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Value in health, 2022-01, Vol.25 (1), p.S82-S82

2022

Volltextzugriff (PDF)

POSB158 Cost-Effectiveness of Obinutuzumab Combined with Chemotherapy As Induction Therapy and Followed By Obinutuzumab Maintenance Therapy for Treatment Naïve Patients with Advanced Follicular Lymphoma in Mainland China

Value in health, 2022-01, Vol.25 (1), p.S91-S91

2022

Volltextzugriff (PDF)

POSA56 A Cost-Effectiveness Analysis of Polatuzumab in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Portugal

Value in health, 2022-01, Vol.25 (1), p.S43-S44

2022

Volltextzugriff (PDF)

PCN104 OBINUTUZUMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: AN IMPORTANT CLINICAL AND COST-EFFECTIVE OPTION FOR HIGH-RISK (INTERMEDIATE/HIGH FLIPI) PATIENTS IN CANADA

Value in health, 2019-05, Vol.22, p.S75-S75

2019

Volltextzugriff (PDF)

PCN245 Opposing Duration of Treatment Effect Assumptions USED in the Health Technology Assessment of a Treatment for Rituximab-Refractory Follicular Lymphoma

Value in health, 2020-12, Vol.23, p.S466-S466

2020

Volltextzugriff (PDF)

Trends in the Incidence of Clavicle Fractures and Surgical Repair in Sweden: 2001-2012

Journal of bone and joint surgery. American volume, 2016-11, Vol.98 (21), p.1837-1842

2016

Volltextzugriff (PDF)

PCN133 - THE SOCIETAL IMPACT OF OBINUTUZUMAB IN THE FIRST LINE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA IN GERMANY

Value in health, 2018-10, Vol.21, p.S37-S37

2018

Volltextzugriff (PDF)

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

Hematological oncology, 2023-06, Vol.41 Suppl 2, p.432

2023

Volltextzugriff (PDF)

Epidemiology of proximal humerus fractures

Archives of osteoporosis, 2015, Vol.10 (1), p.209-209, Article 2

2015

Volltextzugriff (PDF)

Use of the levonorgestrel-releasing intrauterine system and breast cancer

Obstetrics and gynecology (New York. 1953), 2005-10, Vol.106 (4), p.813-817

2005

Volltextzugriff (PDF)

Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone

Annals of hematology, 2017-02, Vol.96 (2), p.253-259

2017

Volltextzugriff (PDF)

Mortality following proximal humerus fracture—a nationwide register study of 147,692 fracture patients in Sweden

Osteoporosis international, 2023-02, Vol.34 (2), p.349-356

2023

Volltextzugriff (PDF)

Cover Image

Orthodontics & craniofacial research, 2018-08, Vol.21 (3)

2018

Volltextzugriff (PDF)

Intraobserver and interobserver reliability of recategorized Neer classification in differentiating 2-part surgical neck fractures from multi-fragmented proximal humeral fractures in 116 patients

Journal of shoulder and elbow surgery, 2018-10, Vol.27 (10), p.1756-1761

2018

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Full Text

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(106)
Berichte
(1)
Texte
(1)

Sprache

Englisch
(108)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Proximal humeral fractures in Sweden—a registry-based study

Postponing elective surgery due to COVID-19 did not decrease the oncological surgery rate in Finland

Cause of death and prognosis of patients (pts) with primary refractory disease, and prognosis of pts reaching PFS24: Descriptive analysis of POLARIX

MSR38 Comparison of Mixture-Cure Model Versus Standard Parametric Survival Model in 1L Diffuse Large B-Cell Lymphoma

CLINICAL OUTCOMES OF PATIENTS WITH INTERMEDIATE‐TO‐HIGH‐RISK FOLLICULAR LYMPHOMA (FL) IN THE GALLIUM PHASE III STUDY

3D follow‐up study of facial asymmetry after developmental dysplasia of the hip

ESTIMATION OF LONG‐TERM SURVIVAL WITH POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB FOR PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)

Outcomes With Surgery vs Functional Bracing for Patients With Closed, Displaced Humeral Shaft Fractures and the Need for Secondary Surgery: A Prespecified Secondary Analysis of the FISH Randomized Clinical Trial

PNS30 COST-EFFECTIVENESS MODELING FRAMEWORK FOR MATCHING-ADJUSTED-INDIRECT-COMPARISONS IN THE PRESENCE OF CURE ESTIMATES

Incidence for volar locking plate removal following distal radius fracture surgery

PCN92 Cost Effectiveness of Obinutuzumab PLUS Chemotherapy Followed By Obinutuzumab Maintenance for Patient with Previously Untreated Advanced-STAGE Follicular Lymphoma in French Setting

POSB109 Cost-Effectiveness and Cost-Utility Analyses of Polatuzumab Vedotin with Bendamustine and Rituximab vs. Bendamustine and Rituximab for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

POSB158 Cost-Effectiveness of Obinutuzumab Combined with Chemotherapy As Induction Therapy and Followed By Obinutuzumab Maintenance Therapy for Treatment Naïve Patients with Advanced Follicular Lymphoma in Mainland China

POSA56 A Cost-Effectiveness Analysis of Polatuzumab in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Portugal

PCN104 OBINUTUZUMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: AN IMPORTANT CLINICAL AND COST-EFFECTIVE OPTION FOR HIGH-RISK (INTERMEDIATE/HIGH FLIPI) PATIENTS IN CANADA

PCN245 Opposing Duration of Treatment Effect Assumptions USED in the Health Technology Assessment of a Treatment for Rituximab-Refractory Follicular Lymphoma

Trends in the Incidence of Clavicle Fractures and Surgical Repair in Sweden: 2001-2012

PCN133 - THE SOCIETAL IMPACT OF OBINUTUZUMAB IN THE FIRST LINE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA IN GERMANY

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

Epidemiology of proximal humerus fractures

Use of the levonorgestrel-releasing intrauterine system and breast cancer

Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone

Mortality following proximal humerus fracture—a nationwide register study of 147,692 fracture patients in Sweden

Cover Image

Intraobserver and interobserver reliability of recategorized Neer classification in differentiating 2-part surgical neck fractures from multi-fragmented proximal humeral fractures in 116 patients

Aktive Filter

Suchergebnisse filtern